Search - tctmd.com

Displaying 841 - 860 of 1457

Sort: Relevancy | Date

Presentation TCT 2013

Distilling the Aortic Stenosis Guidelines (Synthesis of ESC and ACC/AHA): Essentials and Controversies

Presenter: Alec Vahanian

October 27, 2013

Presentation TCT 2013

“Asymptomatic” Severe Aortic Stenosis - Case presentation

Presenter: Philip Green

October 27, 2013

News Daily News

Rule Can Help Distinguish Between Patients Who Need Carotid Stenting vs. Surgery

L.A. McKeown

October 25, 2013

News Daily News

PARTNER: Lung Disease No Barrier to TAVR But Increases Mortality Risk

October 25, 2013

News Daily News

PARTNER: La Enfermedad Pulmonar No es Barrera para la TAVR pero Aumenta el Riesgo de Mortalidad

October 25, 2013

News Daily News

La colocación del stent intracraneal podría ser más segura en ensayos clínicos que en la práctica real

Jason Kahn

October 25, 2013

News Daily News

Intracranial Stenting May Be Safer in Clinical Trials vs. Real-world Practice

Jason Kahn

October 25, 2013

Presentation

Intracranial Stent Placement for Symptomatic Intracranial Stenosis as Part of a Clinical Trial vs. Outside a Clinical Trial

Presenter: Farhan Siddiq

October 24, 2013

News Daily News

Clinical Inoperability in TAVR Patients Carries Worse Prognosis than Technical Factors

October 23, 2013

Presentation

Outcomes of Patients with Chronic Lung Disease and Severe Aortic Stenosis Treated with TAVR vs. Surgical Replacement or Standard Therapy

Presenter: D. Dvir

October 22, 2013

News Industry News

Medtronic to Unveil CoreValve U.S. Pivotal Trial Results at TCT 2013

October 17, 2013

News Daily News

Paclitaxel-Eluting Balloon-Plus-BMS Strategy Fares Poorly vs. EES in De Novo Stenosis

October 15, 2013

News Daily News

La Estrategia Balón liberador de Paclitaxel + SMD es Pobre comparada con los SLE en el Tratamiento de la Estenosis De Novo

October 15, 2013

News Daily News

‘Obesity Paradox’ Observed in TAVR Patients

Caitlin E. Cox

October 15, 2013

Presentation

Elutax Paclitaxel-Eluting Balloon (PEB) Followed by BMS Compared with Xience V DES for Coronary De Novo Stenosis

Presenter: F. Liistro

October 14, 2013

News Daily News

TAVR Patients with Moderate/Severe Mitral Regurgitation Carry Worse Prognosis

October 11, 2013

News Daily News

Small Study Suggests Filter Protection More Effective Than Flow Reversal in Carotid Stenting

L.A. McKeown

October 11, 2013

News Daily News

FFR in Routine Practice Reduces Stenting, Death, MI Rates

Jason Kahn

October 11, 2013

News Daily News

‘Gold Standard’ Imaging Study Undermines Venous Abnormalities Hypothesis in MS

October 11, 2013

News Daily News

Meta-analysis: Women Fare Better Than Men After TAVR Despite More Complications

Yael L. Maxwell

September 27, 2013

Advertisement

Distilling the Aortic Stenosis Guidelines (Synthesis of ESC and ACC/AHA): Essentials and Controversies

“Asymptomatic” Severe Aortic Stenosis - Case presentation

Rule Can Help Distinguish Between Patients Who Need Carotid Stenting vs. Surgery

PARTNER: Lung Disease No Barrier to TAVR But Increases Mortality Risk

PARTNER: La Enfermedad Pulmonar No es Barrera para la TAVR pero Aumenta el Riesgo de Mortalidad

La colocación del stent intracraneal podría ser más segura en ensayos clínicos que en la práctica real

Intracranial Stenting May Be Safer in Clinical Trials vs. Real-world Practice

Intracranial Stent Placement for Symptomatic Intracranial Stenosis as Part of a Clinical Trial vs. Outside a Clinical Trial

Clinical Inoperability in TAVR Patients Carries Worse Prognosis than Technical Factors

Outcomes of Patients with Chronic Lung Disease and Severe Aortic Stenosis Treated with TAVR vs. Surgical Replacement or Standard Therapy

Medtronic to Unveil CoreValve U.S. Pivotal Trial Results at TCT 2013

Paclitaxel-Eluting Balloon-Plus-BMS Strategy Fares Poorly vs. EES in De Novo Stenosis

La Estrategia Balón liberador de Paclitaxel + SMD es Pobre comparada con los SLE en el Tratamiento de la Estenosis De Novo

‘Obesity Paradox’ Observed in TAVR Patients

Elutax Paclitaxel-Eluting Balloon (PEB) Followed by BMS Compared with Xience V DES for Coronary De Novo Stenosis

TAVR Patients with Moderate/Severe Mitral Regurgitation Carry Worse Prognosis

Small Study Suggests Filter Protection More Effective Than Flow Reversal in Carotid Stenting

FFR in Routine Practice Reduces Stenting, Death, MI Rates

‘Gold Standard’ Imaging Study Undermines Venous Abnormalities Hypothesis in MS

Meta-analysis: Women Fare Better Than Men After TAVR Despite More Complications

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content